Pages that link to "Q36263978"

The following pages link to Predicting drug efficacy for cognitive deficits in schizophrenia (Q36263978):

Displaying 49 items.

• What does schizophrenia teach us about antipsychotics? (Q26823906) (← links)
• Prepulse inhibition predicts spatial working memory performance in the inbred Roman high- and low-avoidance rats and in genetically heterogeneous NIH-HS rats: relevance for studying pre-attentive and cognitive anomalies in schizophrenia (Q30403344) (← links)
• Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery (Q30454958) (← links)
• Models of neurodevelopmental abnormalities in schizophrenia (Q30457462) (← links)
• Animal models of schizophrenia. (Q30462828) (← links)
• Are we studying and treating schizophrenia correctly? (Q30465313) (← links)
• Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? (Q30473418) (← links)
• Developing translational animal models for symptoms of schizophrenia or bipolar mania (Q30487857) (← links)
• Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia (Q30489404) (← links)
• The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? (Q30490231) (← links)
• The 5-choice continuous performance test: evidence for a translational test of vigilance for mice (Q33401264) (← links)
• Cognition in mouse models of schizophrenia susceptibility genes (Q33707698) (← links)
• Pharmacological MRI Approaches to Understanding Mechanisms of Drug Action (Q34068271) (← links)
• Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. (Q34283319) (← links)
• mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task (Q34785084) (← links)
• Prediction of treatment outcomes in psychiatry--where do we stand ? (Q35109159) (← links)
• Sustained attention in mice: Expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP) (Q35231692) (← links)
• The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task (Q35740788) (← links)
• Variable prenatal stress results in impairments of sustained attention and inhibitory response control in a 5-choice serial reaction time task in rats. (Q36448887) (← links)
• Measuring Attention in Rodents: Comparison of a Modified Signal Detection Task and the 5-Choice Serial Reaction Time Task (Q36460580) (← links)
• Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function (Q36823176) (← links)
• Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development (Q36935148) (← links)
• Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration (Q37012177) (← links)
• Wayne Fenton's impact on academic neuroscience (Q37076124) (← links)
• A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia (Q37212798) (← links)
• Behavioral paradigms to evaluate PPAR modulation in animal models of brain injury (Q37226637) (← links)
• Asenapine effects in animal models of psychosis and cognitive function (Q37370296) (← links)
• Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment (Q37437840) (← links)
• nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. (Q37465460) (← links)
• Declarative and nondeclarative memory in schizophrenia: What is impaired? What is spared? (Q38373732) (← links)
• Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. (Q40056642) (← links)
• The quest for developing new treatments from imaging techniques: promises, problems and future potential (Q40188554) (← links)
• MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia. (Q41028473) (← links)
• The brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog (Q41879506) (← links)
• Preclinical approaches for drugs targeting cognitive deficits of schizophrenia (Q42908753) (← links)
• Editorial--modeling negative symptoms: what's missing? (Q43000968) (← links)
• Of rats and schizophrenia. (Q43024782) (← links)
• Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia. (Q46004595) (← links)
• Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia (Q46840300) (← links)
• Parametric and pharmacological modulations of latent inhibition in mouse inbred strains (Q46879839) (← links)
• Individual difference in prepulse inhibition does not predict spatial learning and memory performance in C57BL/6 mice (Q47659102) (← links)
• Improvement of attention with amphetamine in low- and high-performing rats. (Q47971648) (← links)
• Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine (Q48165168) (← links)
• Cognitive Functions and Neurodevelopmental Disorders Involving the Prefrontal Cortex and Mediodorsal Thalamus. (Q50276626) (← links)
• British Association for Psychopharmacology Summer Meeting: 23-26 July 2006, Oxford, United Kingdom (Q50790356) (← links)
• Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia (Q51666183) (← links)
• Possible dose-side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophrenia (Q51947237) (← links)
• Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis (Q53400234) (← links)
• Animal Models of Schizophrenia (Q83396618) (← links)